82 related articles for article (PubMed ID: 9288574)
21. Effects of antihyperlipidemic agents on hepatic insulin sensitivity in perfused Goto-Kakizaki rat liver.
Matsuura B; Kanno S; Minami H; Tsubouchi E; Iwai M; Matsui H; Horiike N; Onji M
J Gastroenterol; 2004; 39(4):339-45. PubMed ID: 15168245
[TBL] [Abstract][Full Text] [Related]
22. Effects of pioglitazone on glucose and lipid metabolism in normal and insulin resistant animals.
Ikeda H; Taketomi S; Sugiyama Y; Shimura Y; Sohda T; Meguro K; Fujita T
Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):156-62. PubMed ID: 2334455
[TBL] [Abstract][Full Text] [Related]
23. Tumor necrosis factor-alpha-induced production of plasminogen activator inhibitor 1 and its regulation by pioglitazone and cerivastatin in a nonmalignant human hepatocyte cell line.
Takeshita Y; Takamura T; Hamaguchi E; Shimizu A; Ota T; Sakurai M; Kaneko S
Metabolism; 2006 Nov; 55(11):1464-72. PubMed ID: 17046548
[TBL] [Abstract][Full Text] [Related]
24. Effect of metformin, orlistat and pioglitazone treatment on mean insulin resistance and its biological variability in polycystic ovary syndrome.
Cho LW; Kilpatrick ES; Keevil BG; Coady AM; Atkin SL
Clin Endocrinol (Oxf); 2009 Feb; 70(2):233-7. PubMed ID: 18547343
[TBL] [Abstract][Full Text] [Related]
25. Metformin and atorvastatin combination further protect the liver in type 2 diabetes with hyperlipidaemia.
Matafome P; Louro T; Rodrigues L; Crisóstomo J; Nunes E; Amaral C; Monteiro P; Cipriano A; Seiça R
Diabetes Metab Res Rev; 2011 Jan; 27(1):54-62. PubMed ID: 21218508
[TBL] [Abstract][Full Text] [Related]
26. [Pioglitazone].
Kobayashi M; Iwata M; Hiratani K
Nihon Rinsho; 2002 Sep; 60 Suppl 9():429-37. PubMed ID: 12387029
[No Abstract] [Full Text] [Related]
27. [Mechanisms of thiazolidinedione derivatives for hypoglycemic and insulin sensitizing effects].
Sugiyama Y; Murase K; Ikeda H
Nihon Rinsho; 2000 Feb; 58(2):370-5. PubMed ID: 10707560
[TBL] [Abstract][Full Text] [Related]
28. KB-R7785, a novel matrix metalloproteinase inhibitor, exerts its antidiabetic effect by inhibiting tumor necrosis factor-alpha production.
Morimoto Y; Nishikawa K; Ohashi M
Life Sci; 1997; 61(8):795-803. PubMed ID: 9275009
[TBL] [Abstract][Full Text] [Related]
29. Pioglitazone time-dependently reduces tumour necrosis factor-alpha level in muscle and improves metabolic abnormalities in Wistar fatty rats.
Murase K; Odaka H; Suzuki M; Tayuki N; Ikeda H
Diabetologia; 1998 Mar; 41(3):257-64. PubMed ID: 9541164
[TBL] [Abstract][Full Text] [Related]
30. Hepatic insulin resistance in KKA(y) mice and its amelioration by pioglitazone do not involve alterations in phospholipase C activity.
Bleasdale JE; Swanson ML
Biochim Biophys Acta; 1993 Jun; 1181(3):240-8. PubMed ID: 8391325
[TBL] [Abstract][Full Text] [Related]
31. Effects of combined pioglitazone and metformin on diabetes and obesity in Wistar fatty rats.
Suzuki M; Odaka H; Suzuki N; Sugiyama Y; Ikeda H
Clin Exp Pharmacol Physiol; 2002 Apr; 29(4):269-74. PubMed ID: 11985534
[TBL] [Abstract][Full Text] [Related]
32. Pioglitazone: in vitro effects on rat hepatoma cells and in vivo liver hypertrophy in KKAy mice.
Weinstock RS; Murray FT; Diani A; Sangani GA; Wachowski MB; Messina JL
Pharmacology; 1997 Apr; 54(4):169-78. PubMed ID: 9211562
[TBL] [Abstract][Full Text] [Related]
33. [Insulin resistance and cytokine, cytokine receptor].
Hamaguchi T; Nakajima H; Hanafusa T; Matsuzawa Y
Nihon Rinsho; 2000 Feb; 58(2):320-6. PubMed ID: 10707552
[TBL] [Abstract][Full Text] [Related]
34. Pioglitazone/metformin adduct regulates insulin secretion and inhibits high glucose-induced apoptosis via p21-p53-MDM2 signaling in INS-1 cells.
Liu RX; Ma Y; Hu XL; Liao YP; Hu XN; He BC; Sun WJ
J Cell Biochem; 2018 Jul; 119(7):5449-5459. PubMed ID: 29369427
[TBL] [Abstract][Full Text] [Related]
35. Identification of specific sites in the TNF-alpha molecule promoting insulin resistance in H-411E cells.
Solomon SS; Mishra SK; Palazzolo MR; Postlethwaite AE; Seyer JM
J Lab Clin Med; 1997 Aug; 130(2):139-46. PubMed ID: 9280141
[TBL] [Abstract][Full Text] [Related]
36. Disparate effects of antidiabetic drugs on arterial contraction.
Peuler JD; Miller JA; Bourghli M; Zammam HY; Soltis EE; Sowers JR
Metabolism; 1997 Oct; 46(10):1199-205. PubMed ID: 9322807
[TBL] [Abstract][Full Text] [Related]
37. The protective effect of silk fibroin on high glucose induced insulin resistance in HepG2 cells.
Yang Q; Zhu Z; Wang L; Xia H; Mao J; Wu J; Kato K; Li H; Zhang J; Yamanaka K; An Y
Environ Toxicol Pharmacol; 2019 Jul; 69():66-71. PubMed ID: 30959417
[TBL] [Abstract][Full Text] [Related]
38. Modulation of Insulin Resistance, Dyslipidemia and Serum Metabolome in iNOS Knockout Mice following Treatment with Nitrite, Metformin, Pioglitazone, and a Combination of Ampicillin and Neomycin.
Aggarwal H; Pathak P; Kumar Y; Jagavelu K; Dikshit M
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008623
[TBL] [Abstract][Full Text] [Related]
39. Tumor necrosis factor alpha: a key component of the obesity-diabetes link.
Hotamisligil GS; Spiegelman BM
Diabetes; 1994 Nov; 43(11):1271-8. PubMed ID: 7926300
[TBL] [Abstract][Full Text] [Related]
40. Synergistic action of ursolic acid and metformin in experimental model of insulin resistance and related behavioral alterations.
Mourya A; Akhtar A; Ahuja S; Sah SP; Kumar A
Eur J Pharmacol; 2018 Sep; 835():31-40. PubMed ID: 30075220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
